THOMAS WINEGARDEN
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry
- Where
- Chanhassen, MN
- NPI
- 1194707828
- Received
- $55,158 in 150 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 35 | $16,723 |
| 2024 | General payment | 29 | $15,032 |
| 2023 | General payment | 5 | $101 |
| 2022 | General payment | 16 | $1,205 |
| 2021 | General payment | 6 | $1,956 |
| 2020 | General payment | 16 | $6,193 |
| 2019 | General payment | 43 | $13,944 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 34 | $31,209 | 2024–2025 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $7,973 | 2019–2025 |
| Otsuka America Pharmaceutical, Inc. | 18 | $7,867 | 2019–2021 |
| Allergan, Inc. | 17 | $4,933 | 2019–2020 |
| ABBVIE INC. | 10 | $1,141 | 2021–2022 |
| Sunovion Pharmaceuticals Inc. | 3 | $1,061 | 2020 |
| Lundbeck LLC | 8 | $121 | 2019–2025 |
| Neuronetics, Inc. | 7 | $116 | 2019–2025 |
| Supernus Pharmaceuticals, Inc. | 4 | $76 | 2024–2025 |
| Alkermes, Inc. | 6 | $75 | 2019–2023 |
| Vanda Pharmaceuticals Inc. | 4 | $70 | 2024–2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $68 | 2022–2025 |
| Teva Pharmaceuticals USA, Inc. | 3 | $62 | 2022–2025 |
| IRONSHORE PHARMACEUTICALS INC. | 3 | $55 | 2019–2024 |
| Sage Therapeutics, LLC | 3 | $49 | 2024 |
| LivaNova USA, Inc. | 1 | $38 | 2019 |
| Indivior Inc. | 1 | $33 | 2024 |
| Tris Pharma Inc | 2 | $33 | 2023–2024 |
| Tempus AI, Inc | 1 | $28 | 2024 |
| Almatica Pharma LLC | 2 | $27 | 2022 |
| Eisai Inc. | 1 | $20 | 2020 |
| Lilly USA, LLC | 1 | $15 | 2025 |
| Vertical Pharmaceuticals, LLC | 1 | $14 | 2019 |
| Novo Nordisk Inc | 1 | $14 | 2025 |
| Collegium Pharmaceutical, Inc. | 1 | $14 | 2025 |
| ACADIA Pharmaceuticals Inc | 1 | $12 | 2019 |
| Brainsway USA INC | 1 | $11 | 2019 |
| Corium, LLC | 1 | $9 | 2024 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 26 | $29,767 |
| Consulting Fee | 9 | $21,735 |
| Food and Beverage | 108 | $1,943 |
| Travel and Lodging | 6 | $1,697 |
| Education | 1 | $14 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-18 | E.R. Squibb & Sons, L.L.C. | $11 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-12 | Neuronetics, Inc. | $24 | Food and Beverage | Cash or cash equivalent | NEUROSTAR TMS THERAPY SYSTEM Device, NEUROSTAR TMS THERAPY SYSTEM | 2025 | |
| 2025-12-12 | Neuronetics, Inc. | $24 | Food and Beverage | Cash or cash equivalent | NEUROSTAR TMS THERAPY SYSTEM Device, NEUROSTAR TMS THERAPY SYSTEM | 2025 | |
| 2025-11-25 | E.R. Squibb & Sons, L.L.C. | $7,015 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-11-25 | E.R. Squibb & Sons, L.L.C. | $10 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $464 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $326 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $134 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $64 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $51 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $49 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $29 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $29 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-08 | Collegium Pharmaceutical, Inc. | $14 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-09-24 | E.R. Squibb & Sons, L.L.C. | $8 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-22 | Lilly USA, LLC | $15 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-07-30 | Supernus Pharmaceuticals, Inc. | $15 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-07-29 | Teva Pharmaceuticals USA, Inc. | $14 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-06-09 | Vanda Pharmaceuticals Inc. | $13 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-06-04 | Supernus Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-05-07 | E.R. Squibb & Sons, L.L.C. | $1,840 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-04-22 | Vanda Pharmaceuticals Inc. | $14 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-04-16 | E.R. Squibb & Sons, L.L.C. | $460 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-04-15 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-04-11 | E.R. Squibb & Sons, L.L.C. | $690 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-04-08 | Lundbeck LLC | $17 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-02 | Novo Nordisk Inc | $14 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-04-01 | E.R. Squibb & Sons, L.L.C. | $920 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-03-20 | E.R. Squibb & Sons, L.L.C. | $230 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-03-12 | Takeda Pharmaceuticals U.S.A., Inc. | $13 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-03-11 | E.R. Squibb & Sons, L.L.C. | $1,840 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-03-06 | E.R. Squibb & Sons, L.L.C. | $460 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-03-04 | E.R. Squibb & Sons, L.L.C. | $1,840 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-02-18 | E.R. Squibb & Sons, L.L.C. | $7 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2024-12-31 | E.R. Squibb & Sons, L.L.C. | $14 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Psychiatry/Psychology | 2024 | |
| 2024-12-04 | Sage Therapeutics, LLC | $19 | Food and Beverage | In-kind items and services | ZURZUVAE Drug, PSYCHIATRY/PSYCHOLOGY | 2024 | |
| 2024-11-12 | E.R. Squibb & Sons, L.L.C. | $460 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-11-08 | E.R. Squibb & Sons, L.L.C. | $5,980 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-11-05 | Indivior Inc. | $33 | Food and Beverage | In-kind items and services | SUBLOCADE Drug, OUD | 2024 | |
| 2024-11-01 | Supernus Pharmaceuticals, Inc. | $21 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2024 | |
| 2024-10-04 | E.R. Squibb & Sons, L.L.C. | $570 | Travel and Lodging | Cash or cash equivalent | 2024 | ||
| 2024-10-04 | E.R. Squibb & Sons, L.L.C. | $226 | Travel and Lodging | Cash or cash equivalent | 2024 | ||
| 2024-10-04 | E.R. Squibb & Sons, L.L.C. | $124 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-10-04 | E.R. Squibb & Sons, L.L.C. | $58 | Travel and Lodging | Cash or cash equivalent | 2024 | ||
| 2024-10-04 | E.R. Squibb & Sons, L.L.C. | $49 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-10-04 | E.R. Squibb & Sons, L.L.C. | $49 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-10-04 | E.R. Squibb & Sons, L.L.C. | $29 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-10-04 | E.R. Squibb & Sons, L.L.C. | $29 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-10-04 | Supernus Pharmaceuticals, Inc. | $21 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2024 | |
| 2024-09-18 | Lundbeck LLC | $15 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-09-13 | E.R. Squibb & Sons, L.L.C. | $1,610 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2024 | ||
| 2024-09-03 | Vanda Pharmaceuticals Inc. | $22 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2024 | |
| 2024-08-20 | Takeda Pharmaceuticals U.S.A., Inc. | $14 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 | |
| 2024-08-12 | E.R. Squibb & Sons, L.L.C. | $5,520 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-07-31 | Tempus AI, Inc | $28 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-06-19 | Vanda Pharmaceuticals Inc. | $20 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2024 | |
| 2024-04-30 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-04-24 | Corium, LLC | $9 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2024 | |
| 2024-04-05 | Sage Therapeutics, LLC | $13 | Food and Beverage | In-kind items and services | ZURZUVAE Drug, PSYCHIATRY/PSYCHOLOGY | 2024 | |
| 2024-04-02 | Lundbeck LLC | $13 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-03-14 | IRONSHORE PHARMACEUTICALS INC. | $20 | Food and Beverage | Cash or cash equivalent | JORNAY PM Drug, CENTRAL NERVOUS SYSTEM STIMULANT | 2024 | |
| 2024-02-07 | Sage Therapeutics, LLC | $16 | Food and Beverage | In-kind items and services | ZURZUVAE Drug, PSYCHIATRY/PSYCHOLOGY | 2024 | |
| 2024-01-09 | Tris Pharma Inc | $18 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2024 | |
| 2023-11-28 | Lundbeck LLC | $19 | Food and Beverage | Cash or cash equivalent | BRINTELLIX Drug, PSYCHIATRY | 2023 | |
| 2023-06-27 | Tris Pharma Inc | $14 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2023 | |
| 2023-06-14 | Teva Pharmaceuticals USA, Inc. | $36 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2023 | |
| 2023-06-09 | Lundbeck LLC | $16 | Food and Beverage | Cash or cash equivalent | BRINTELLIX Drug, PSYCHIATRY | 2023 | |
| 2023-04-26 | Alkermes, Inc. | $14 | Education | In-kind items and services | Vivitrol Drug, CNS | 2023 | |
| 2022-12-08 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $12 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 | |
| 2022-11-02 | ABBVIE INC. | $1,050 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-10-28 | Alkermes, Inc. | $11 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2022 | |
| 2022-10-13 | Almatica Pharma LLC | $13 | Food and Beverage | In-kind items and services | CITALOPRAM Drug, ANTI-DEPRESSION | 2022 | |
| 2022-08-23 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-08-04 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-07-07 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-06-07 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-05-13 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-04-21 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-04-07 | Alkermes, Inc. | $12 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2022 | |
| 2022-03-31 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-02-01 | Teva Pharmaceuticals USA, Inc. | $12 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2022 | |
| 2022-01-27 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-01-20 | Alkermes, Inc. | $12 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2022 | |
| 2022-01-05 | Almatica Pharma LLC | $14 | Food and Beverage | In-kind items and services | GRALISE Drug, POSTHERPETIC NEURALGIA | 2022 | |
| 2021-12-22 | ABBVIE INC. | $25 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-08-04 | Otsuka America Pharmaceutical, Inc. | $351 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-08-04 | Otsuka America Pharmaceutical, Inc. | $87 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-05-19 | Alkermes, Inc. | $11 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2021 | |
| 2021-02-24 | Otsuka America Pharmaceutical, Inc. | $1,470 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2021-02-17 | Lundbeck LLC | $11 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2021 | |
| 2020-12-23 | Otsuka America Pharmaceutical, Inc. | $1,134 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2020 | |
| 2020-12-02 | Otsuka America Pharmaceutical, Inc. | $351 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2020 | |
| 2020-11-18 | Sunovion Pharmaceuticals Inc. | $11 | Food and Beverage | In-kind items and services | LATUDA Drug, CNS | 2020 | |
| 2020-11-12 | Otsuka America Pharmaceutical, Inc. | $351 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2020 | |
| 2020-09-29 | Sunovion Pharmaceuticals Inc. | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LATUDA Drug, CNS | 2020 | |
| 2020-09-04 | Allergan, Inc. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2020 | |
| 2020-08-19 | Allergan, Inc. | $22 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2020 | |
| 2020-06-11 | Eisai Inc. | $20 | Food and Beverage | Cash or cash equivalent | Dayvigo Drug, Neurology | 2020 | |
| 2020-02-26 | Allergan, Inc. | $1,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2020 | |
| 2020-02-26 | Allergan, Inc. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2020 | |
| 2020-02-18 | Sunovion Pharmaceuticals Inc. | $350 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LATUDA Drug, CNS | 2020 | |
| 2020-02-05 | Neuronetics, Inc. | $4 | Food and Beverage | In-kind items and services | NEUROSTAR TMS THERAPY Device, NEUROSTAR TMS THERAPY | 2020 | |
| 2020-01-29 | Allergan, Inc. | $1,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2020 | |
| 2020-01-29 | Allergan, Inc. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2020 | |
| 2020-01-24 | Allergan, Inc. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2020 | |
| 2020-01-22 | Otsuka America Pharmaceutical, Inc. | $4 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2020 | |
| 2019-12-18 | Lundbeck LLC | $16 | Food and Beverage | Cash or cash equivalent | BRINTELLIX Drug, PSYCHIATRY | 2019 | |
| 2019-12-17 | Otsuka America Pharmaceutical, Inc. | $1,872 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2019 | |
| 2019-12-02 | Takeda Pharmaceuticals U.S.A., Inc. | $7 | Food and Beverage | In-kind items and services | Trintellix Drug, Central Nervous System (CNS) | 2019 | |
| 2019-11-06 | Otsuka America Pharmaceutical, Inc. | $14 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2019 | |
| 2019-10-30 | Allergan, Inc. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2019 | |
| 2019-10-14 | Otsuka America Pharmaceutical, Inc. | $5 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2019 | |
| 2019-09-17 | Otsuka America Pharmaceutical, Inc. | $1,872 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2019 | |
| 2019-09-16 | Otsuka America Pharmaceutical, Inc. | $5 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2019 | |
| 2019-09-11 | IRONSHORE PHARMACEUTICALS INC. | $17 | Food and Beverage | In-kind items and services | Jornay PM 20mg capsules (Bottle of 100) Drug, Central nervous system (CNS) stimulant | 2019 | |
| 2019-08-25 | Takeda Pharmaceuticals U.S.A., Inc. | $7 | Food and Beverage | In-kind items and services | Trintellix Drug, Central Nervous System (CNS) | 2019 | |
| 2019-08-21 | Allergan, Inc. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2019 | |
| 2019-08-20 | Neuronetics, Inc. | $7 | Food and Beverage | In-kind items and services | NEUROSTAR TMS THERAPY Device, NEUROSTAR TMS THERAPY | 2019 | |
| 2019-08-06 | LivaNova USA, Inc. | $38 | Food and Beverage | In-kind items and services | VNS Therapy Device, Cardiology/Vascular Diseases | 2019 | |
| 2019-07-30 | Allergan, Inc. | $9 | Food and Beverage | In-kind items and services | VIIBRYD Drug, NEUROSCIENCE | 2019 | |
| 2019-07-25 | Otsuka America Pharmaceutical, Inc. | $246 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2019 | |
| 2019-07-10 | IRONSHORE PHARMACEUTICALS INC. | $16 | Food and Beverage | In-kind items and services | Jornay PM 20mg capsules (Bottle of 100) Drug, Central nervous system (CNS) stimulant | 2019 | |
| 2019-07-08 | Neuronetics, Inc. | $8 | Food and Beverage | In-kind items and services | NEUROSTAR TMS THERAPY Device, NEUROSTAR TMS THERAPY | 2019 | |
| 2019-07-08 | Allergan, Inc. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2019 | |
| 2019-06-26 | Allergan, Inc. | $1,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2019 | |
| 2019-06-26 | Allergan, Inc. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2019 | |
| 2019-06-13 | Otsuka America Pharmaceutical, Inc. | $82 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2019 | |
| 2019-06-12 | Takeda Pharmaceuticals U.S.A., Inc. | $10 | Food and Beverage | In-kind items and services | Trintellix Drug, Central Nervous System (CNS) | 2019 | |
| 2019-06-05 | Otsuka America Pharmaceutical, Inc. | $4 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2019 | |
| 2019-05-20 | Allergan, Inc. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2019 | |
| 2019-05-03 | Allergan, Inc. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2019 | |
| 2019-04-26 | Takeda Pharmaceuticals U.S.A., Inc. | $1,320 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Trintellix Drug, Central Nervous System (CNS) | 2019 | |
| 2019-04-23 | Alkermes, Inc. | $11 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2019 | |
| 2019-04-10 | Neuronetics, Inc. | $10 | Food and Beverage | In-kind items and services | NEUROSTAR TMS THERAPY Device, NEUROSTAR TMS THERAPY | 2019 | |
| 2019-03-21 | Takeda Pharmaceuticals U.S.A., Inc. | $1,320 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Trintellix Drug, Central Nervous System (CNS) | 2019 | |
| 2019-03-21 | Takeda Pharmaceuticals U.S.A., Inc. | $1,320 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Trintellix Drug, Central Nervous System (CNS) | 2019 | |
| 2019-03-21 | Takeda Pharmaceuticals U.S.A., Inc. | $1,320 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Trintellix Drug, Central Nervous System (CNS) | 2019 | |
| 2019-03-21 | Takeda Pharmaceuticals U.S.A., Inc. | $1,320 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Trintellix Drug, Central Nervous System (CNS) | 2019 | |
| 2019-03-20 | ACADIA Pharmaceuticals Inc | $12 | Food and Beverage | In-kind items and services | NUPLAZID Drug, PARKINSONS DISEASE PSYCHOSIS | 2019 | |
| 2019-03-06 | Neuronetics, Inc. | $36 | Food and Beverage | In-kind items and services | NEUROSTAR TMS THERAPY Device, NEUROSTAR TMS THERAPY | 2019 | |
| 2019-03-01 | Otsuka America Pharmaceutical, Inc. | $3 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2019 | |
| 2019-02-21 | Otsuka America Pharmaceutical, Inc. | $4 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2019 | |
| 2019-02-15 | Allergan, Inc. | $7 | Food and Beverage | In-kind items and services | VIIBRYD Drug, NEUROSCIENCE | 2019 | |
| 2019-02-15 | Allergan, Inc. | $1 | Food and Beverage | In-kind items and services | VIIBRYD Drug, NEUROSCIENCE | 2019 | |
| 2019-02-13 | Vertical Pharmaceuticals, LLC | $14 | Food and Beverage | In-kind items and services | RELEXXII Drug, ADHD | 2019 | |
| 2019-02-11 | Lundbeck LLC | $11 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2019 | |
| 2019-01-23 | Otsuka America Pharmaceutical, Inc. | $5 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2019 | |
| 2019-01-10 | Brainsway USA INC | $11 | Food and Beverage | Cash or cash equivalent | Brainsway Deep TMS Device, Transcranial Magnetic Stimulation | 2019 | |
| 2019-01-07 | Takeda Pharmaceuticals U.S.A., Inc. | $1,320 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Trintellix Drug, Central Nervous System (CNS) | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Chanhassen, MN, county Carver County, MN, state Minnesota; placed by its city name.
| Measure | Place (city or town) Chanhassen, MN | County Carver County, MN | State Minnesota |
|---|---|---|---|
| Population B01003 | 26,006 | 110,041 | 5,739,445 |
| Population, 2020 census P1 | 25,947 | 106,922 | 5,706,494 |
| Median age B01002 | 41.5 | 39.0 | 38.8 |
| Under 18 B01001 | 24.9% | 25.2% | 22.9% |
| 65 and over B01001 | 15.4% | 14.5% | 17.3% |
| Households B11001 | 9,780 | 41,175 | 2,307,955 |
| Foreign born B05002 | 9.0% | 5.6% | 8.7% |
| Median household income B19013 | $143,651 | $125,946 | $89,062 |
| Median family income B19113 | $179,894 | $154,249 | $113,993 |
| Per capita income B19301 | $76,879 | $60,893 | $48,237 |
| Poverty rate B17001 | 2.9% | 4.4% | 9.3% |
| Unemployment rate B23025 | 3.2% | 3.1% | 4.1% |
| Civilian labor force B23025 | 14,318 | 62,717 | 3,119,042 |
| Mean commute (minutes) B08013 | 22.3 | 25.6 | 22.7 |
| Bachelor's degree or higher B15003 | 64.1% | 50.4% | 39.4% |
| Housing units B25001 | 10,186 | 42,270 | 2,545,030 |
| Owner-occupied B25003 | 84.1% | 81.5% | 72.2% |
| Renters B25003 | 15.9% | 18.5% | 27.8% |
| Median home value B25077 | $566,300 | $453,600 | $329,300 |
| Median gross rent B25064 | $1,831 | $1,514 | $1,280 |
| White, not Hispanic B03002 | 83.7% | 85.5% | 75.9% |
| Black B03002 | 1.3% | 1.6% | 6.9% |
| Hispanic or Latino B03002 | 3.6% | 5.1% | 6.4% |
| Asian B03002 | 5.9% | 3.3% | 5.1% |
| American Indian and Alaska Native B03002 | 0.1% | 0.1% | 0.7% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Chanhassen, MN.
Comments